Market Cap

Insulet Corporation Market Capitalization:

$13.95 Billion

USD as of Jan. 1, 2024

business Insulet Corporation Company Profile

Insulet Corporation Main Stock Listing

NASDAQ: PODD

Market Capitalization History of Insulet Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $192.67 B
Stryker Corporation $113.24 B
Medtronic $111.60 B
Boston Scientific Corporation $85.22 B
Shenzhen Mindray Bio-Medical Electronics Co. Ltd $49.33 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Insulet Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2024 $13.95 B -29.80%
Jan. 1, 2023 $19.88 B 19.17%
Jan. 1, 2022 $16.68 B -7.18%
Jan. 1, 2021 $17.97 B 37.69%
Jan. 1, 2020 $13.05 B 138.99%
Jan. 1, 2019 $5.46 B 6.09%
Jan. 1, 2018 $5.15 B 83.97%
Jan. 1, 2017 $2.80 B 25.38%
Jan. 1, 2016 $2.23 B 12.90%
Jan. 1, 2015 $1.98 B -31.65%
Jan. 1, 2014 $2.89 B 86.39%
Jan. 1, 2013 $1.55 B 18.55%
Jan. 1, 2012 $1.31 B 14.27%
Jan. 1, 2011 $1.15 B 24.94%
Jan. 1, 2010 $916.7 M 71.66%
Jan. 1, 2009 $534.0 M -59.92%
Jan. 1, 2008 $1.33 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Insulet Corporation Categories

United States languages Healthcare languages Medical Devices
United States Healthcare United States Medical Devices

Stocks & Indices

Insulet Corporation has the following listings and related stock indices.


Stock: NASDAQ: PODD

Stock: FSX: GOV

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.